Table 3.
Variable | β | p | Total R2 | R2 Δ | p |
---|---|---|---|---|---|
Model 1: IL-6 (log10 transformation) | |||||
Step 1 | .17 | .17 | <.01 | ||
Gender | −.01 | .92 | |||
Age | .18 | .08 | |||
Body Mass Index (BMI) | .33 | <.01 | |||
Statin Use | −.01 | .91 | |||
Beta-blocker Use | .16 | .11 | |||
Step 2 | .18 | .01 | .22 | ||
Positive Relationships | −.12 | .22 | |||
Step 3 | .18 | .002 | .59 | ||
Positive Relationships x Gender | −.17 | .59 | |||
Step 4 | .18 | .001 | .77 | ||
Positive Relationships2 | −.02 | .77 | |||
Step 5 | .19 | .001 | .74 | ||
Positive Relationships2 x Gender | −.04 | .75 | |||
Model 2: IL-6 (log10 transformation) | |||||
Step 1 | .17 | .17 | <.01 | ||
Gender | −.01 | .92 | |||
Age | .18 | .07 | |||
Body Mass Index (BMI) | .33 | <.01 | |||
Statin Use | −.01 | .91 | |||
Beta-blocker Use | .16 | .11 | |||
Step 2 | .17 | .003 | .58 | ||
Autonomy | −.05 | .58 | |||
Step 3 | .17 | .001 | .70 | ||
Autonomy x Gender | −.12 | .70 | |||
Step 4 | .17 | .000 | .85 | ||
Autonomy2 | −.02 | .85 | |||
Step 5 | .21 | .04 | .04 | ||
Autonomy2 x Gender | .69 | .04 |
Note.
p < .05. For R2 values, an asterisk indicates that the F value for the ANOVA of the full model at that step is significant. For ΔR2, an asterisk indicates that the inclusion of that step’s novel predictor produced an F value than was significantly greater than that of the previous model.